LDS/Medical Tests/Leishmania (Visceral Leishmaniasis) Antibody, IgG

Leishmania (Visceral Leishmaniasis) Antibody, IgG

Leishmaniasis is a disease caused by the intracellular protozoa Leishmania. The infection occurs after the bite of a female sandfly (Phlebotomus and Lutzomyia species) that carry the parasite. More than twenty species of Leishmania have been reported to cause human infections. The most known disease-causing Leishmania protozoa are Leishmania donovani, L. chagasi, L. infantum and L. tropica.

The most common diseases caused by Leishmania are cutaneous Leishmaniasis (most commonly known as white leprosy and black water (kala-azar), visceral Leishmaniasis and mucosal Leishmaniasis. The diseases have a broad spectrum of severity and manifestations, can be clinical or sub-clinical. Symptoms include fever, weight loss, cachexia, hepatosplenomegaly and pancytopenia.

Identification of the infecting parasite is important for diagnosis and treatment as well as for prognostic and epidemiologic reasons. There are several methods for detection and identification of Leishmania parasite from collected specimen. The most common methods are direct detection of parasites by microscopic examination from clinical specimens or by culture. However, all Leishmania species are morphologically very similar and species identification is not possible using either of these techniques. The detection and differentiation of Leishmania species is important and can be done by molecular methods such as Polymerase Chain Reaction (PCR). This method can detect the parasite from any specimen with the highest specificity and sensitivity. There are several published PCR methods for detection of Leishmania species that can be used for these purposes. The detection of serum antibodies to Leishmania is an alternative noninvasive sensitive (95%-100%) method for the diagnosis of active, visceral leishmaniasis.

Diagnosis of Leishmaniasis

Disease management and therapy monitoring

A positive result is consistent with a diagnosis of active visceral leishmaniasis.

Negative (Non-reactive)

Chemiluminescent immunoassay, enzyme immunoassay, enzyme-linked immunosorbent assay (ELISA).

Serum (SST).

Stability

  • Ambient: 3-7 days
  • Refrigerated: 7-14 Days
CBC, PT, PTT, Leishmaniasis (Visceral) Antibody, Parasites Smear (Giemsa Stain), Hepatic Function Panel (Liver Panel), amylase, lipase, Bone Marrow Biopsy and Aspiration, Skin biopsy
1-5 days
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login